Active	Status	Sponsor type	Region	Phase	Filter
8 Active 0 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Patel, Vishal
FRESH, NCT05639543: FXR Effect on Severe Alcohol-Associated Hepatitis () Study	Recruiting	2	50	Europe, US	INT-787, Placebo	Intercept Pharmaceuticals	Alcohol Associated Hepatitis	12/24	12/24
ISAIAH, NCT03775109: IL-1 Signal Inhibition in Alcoholic Hepatitis	Recruiting	2	1300	Europe	Canakinumab 150mg/ml solution for injection, Placebo	Imperial College London, Novartis Pharmaceuticals	Alcoholic Hepatitis	05/24	05/24